In cancer patients with lung adenocarcinoma, the survival curve analysis indicated that the population with higher expression of PDK4 (Figure 4D–4F), FMO2 (Figure 4G–4I), or FABP4 (Figure 4J) is correlated with better survival rates. Here, FABP4 is linked to lung adenocarcinoma.